Pharmafile Logo

Wilmington Healthcare appoints new Solutions Director

May 27, 2021 | NHS, Promotion, healthcare 

Kirsty Fryer has been promoted to the role of Solutions Director for Wilmington Healthcare

Wilmington Healthcare, a market leader in the provision of data, insight and intelligence for pharma and medtech companies, has announced the promotion of Kirsty Fryer to the role of Solutions Director.

In her new role, Kirsty will be responsible for the Quantis portfolio of products offered by Wilmington Healthcare, leading the team as they continue to deliver outstanding service and solutions to the organisation’s customers. Bringing together all disciplines, from analytical, development, commercial and marketing to underpin Wilmington Healthcare’s ambitious growth plans, Kirsty will ensure customers continue to receive trusted insight and real-world data solutions.

Kirsty steps up to the role having been Solutions Consultant since November 2017 and a valued member of the Wilmington Healthcare team since 2015. In this time, she has developed her career from bespoke researcher supporting the organisation’s understanding of the healthcare ecosystem before joining the solutions team working with real-world evidence – transforming data-led insight into core messages and potential implications. With a PhD in Neurophysiology from the University of Nottingham and currently undertaking an MBA with senior leadership focus she brings a wealth of expertise to the role alongside her existing client relationships.

Welcoming the appointment Jonathan Carney, of Wilmington Healthcare, says: “Kirsty has been a huge asset to Wilmington Healthcare since she joined the company in 2015. Her promotion to lead one of our key growth products in the role of Solutions Director is recognition for her passion, energy and commitment in delivering the very best for our customers combined with her extensive knowledge of our products and the impact they help to make in shaping sustainable commercial and partnership strategies for our customers. Through Kirsty’s appointment we will be building upon our market credentials as a trusted, leading organisation in the Healthcare Insight arena.”

Kirsty Fryer adds: ‘I’m proud of my work over the last five years within Wilmington Healthcare and I’m excited to guide our fantastic team as we continue to provide bespoke, real-world insight to meet the individual needs of our customers in parallel with the evolving needs of the NHS in this new era of healthcare impacted by the COVID-19 pandemic.”

This content was provided by Wilmington Healthcare

Company Details

 Latest Content from  Wilmington Healthcare 

Unique forum will unite NHS and industry to drive innovation

HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare

How can pharma engage with key decision-makers in new, collaborative NHS care models?

Paul Midgley, Sue Thomas, Steve How and Oli Hudson, of Wilmington Healthcare, explore how pharma should adapt its approach

HSJ Awards open for entry with promise to champion NHS on its 70th anniversary

HSJ Awards open for entry with promise to champion NHS on its 70th anniversary

Wilmington Healthcare survey finds many doctors fear the NHS will fall victim to another ransomware attack

Following the ransomware attack that wreaked havoc on NHS IT systems last year and resulted in major disruption to patient care, the majority of doctors surveyed by healthcare intelligence provider...

Innovative NHS suppliers scoop HSJ Partnership Awards

Winners include pharma, medtech, healthcare consultants and IT specialists. Innovative pharma and medtech companies have been honoured in an awards scheme run by Health Service Journal (HSJ), the news and...

Managing local population needs is key for the NHS

Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore population-based planning in the NHS and what this means for pharma

Large-scale NHS commissioning models require new partnership approach from pharma

Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore how pharma should respond to the NHS’s move towards more collaborative, joined up working

Leading NHS suppliers highlighted in shortlist for new HSJ awards

The finalists for the first HSJ Healthcare Partnership Awards have been announced. The awards serve to recognise and celebrate those suppliers who work in partnerships with the NHS to drive...

Shining a light on the true cost of patient care

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore how the proposed national patient data sharing scheme would change the NHS

How can pharma engage with the top performing STPs?

The recent announcement by Health Secretary Jeremy Hunt on which Sustainability and Transformation Partnerships (STPs) would benefit from a share of the £325m capital funding allocated in the Spring Budget,...